PMI Picard Medical, Inc.

NEUTRAL Impact: 3/10 8-K
Horizon months Filed Feb 26, 2026 Processed 3mo ago SEC 0001829126-26-001652
8-K context-dependent: Items 7.01
Final — all horizons settled through T+60d
PMI ▼ -87.74% at T+60d
NEUTRAL call ✗ call lost -87.74% · α vs SPY -95.49% · entry $1.15 → $0.1410
Currently $0.1790 · -84.43% from $1.15 entry
Entry anchored
Feb 25, 03:59 PM ET
via Databento tick
T+1d
-6.09%
call -6.09% · α -5.63%
$1.08
settled 4mo ago
T+5d
-6.96%
call -6.96% · α -5.83%
$1.07
settled 3mo ago
T+20d
-12.17%
call -12.17% · α -5.77%
$1.01
settled 3mo ago
T+60d
-87.74%
call -87.74% · α -95.49%
$0.1410
settled 23d ago

Price Chart

Loading chart...

Executive Summary

Picard Medical, Inc. announced its participation in the inaugural 'Hands-On Training Day' at the Technology and Heart Failure Therapeutics 2026 conference in Boston on March 1, 2026. The event will feature interactive clinical training on the SynCardia Total Artificial Heart, led by company clinical specialists, as part of its commercial expansion and clinician education strategy.

Actionable Insight

This filing is informational and reflects ongoing efforts to expand clinical adoption of the SynCardia Total Artificial Heart. Traders should monitor future commercial metrics such as implant volume, revenue trends, or new center adoption for signs of progress, but no immediate financial impact is expected from this announcement.

Key Facts

  • Picard Medical will participate in the 'Hands-On Training Day' at the THT 2026 conference on March 1, 2026, in Boston.
  • The training is an interactive, case-based program focused on real-world application of the SynCardia Total Artificial Heart for advanced heart failure patients.
  • Senior Clinical Specialists Lauren Wallace and Skyler Peffly will lead the session, offering hands-on experience with the Companion 2 Driver, Freedom Portable Driver, and the SynCardia Total Artificial Heart.
  • The company states this event supports its commercial expansion strategy and aims to strengthen clinical partnerships and global adoption.
  • No financial data, guidance updates, or material business developments were disclosed.

Financial Impact

No direct financial impact disclosed; event supports long-term commercial and educational outreach.

Risk Factors

  • No financial or operational data was provided, limiting near-term trading relevance.
  • Investor sentiment may be influenced by perceived momentum in clinical adoption, but this remains speculative without supporting metrics.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-001652
Document: picardmedical_ex99-1.htm0001829126-26-001652
Document: 0001829126-26-001652-index-headers.html0001829126-26-001652
Document: 0001829126-26-001652-index.html0001829126-26-001652
Document: 0001829126-26-001652.txt0001829126-26-001652
15 reports for PMI
Performance horizon
50% Hit rate 4 of 8 directional calls best @ T+20▲ +78.96%Apr 13, 2026
Filters
Rows
Reports for PMI — sortable, filterable
Type Now
Jun 2, 2026
11d ago
Press Release
BULLISH ★ 6/10
$0.2700 $0.3080▲ +14.07%▲ +14.77%$0.1790 (−33.70%)
Jun 2, 2026
11d ago
8-K
BEARISH ★ 5/10
$0.2700 $0.3080▼ −14.07%▼ −14.77%$0.1790 (+33.70%)
Jun 1, 2026
12d ago
EFFECT
BEARISH ★ 5/10
$0.1680 $0.2700▼ −60.71%▼ −60.57%$0.1790 (−6.55%)
May 29, 2026
15d ago
8-K
MIXED ★ 6/10
$0.1480 $0.1680▲ +13.51%▲ +13.26%$0.1790 (+20.95%)
May 29, 2026
15d ago
Press Release
NEUTRAL ★ 4/10
$0.1480 $0.1684▲ +13.78%▲ +13.51%$0.1790 (+20.95%)
May 21, 2026
23d ago
Press Release
BEARISH ★ 7/10
$0.1410 $0.1510▼ −7.09%▼ −6.65%$0.1790 (−26.95%)
May 20, 2026
23d ago
S-1
NEUTRAL ★ 4/10
$0.1410 $0.1510▲ +7.09%▲ +6.65%$0.1790 (+26.95%)
May 6, 2026
5w ago
424B4
BEARISH ★ 8/10
$0.2320 $0.2210▲ +4.74%▲ +4.41%$0.1790 (+22.84%)
May 5, 2026
5w ago
8-K
BEARISH ★ 8/10
$0.2100 $0.2320▼ −10.48%▼ −9.09%$0.1790 (+14.76%)
Apr 22, 2026
7w ago
8-K
BULLISH ★ 7/10
$0.9070 $0.8430▼ −7.06%▼ −6.66%$0.1790 (−80.26%)
Showing 10 of 15

US Market Status

Market Closed — Opens Mon (49h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access